Three must-own cancer stocks for your biotechnology portfolio By: MarketWatch June 19, 2017 at 12:25 PM EDT Michael Brush describes medical advances that can save lives — and make you money. Read More >> Related Stocks: Adaptimmune Ther ADR Bluebird Bio Bristol-Myers Squibb Celgene Corp Cellectis S.A. ADR Gsk Plc ADR Incyte Corp Johnson & Johnson Merck & Co Newlink Genetics Cor Novartis Ag ADR Pfizer Range Cancer Therapeutics Index Roche Holding AG Basel American Depositary Shares